SCHEMBL12425596

SCHEMBL12425596

CC(C)c1[nH]c2ccccc2c1CCc1ccncc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TBXAS1 P24557 1/20 0.56
CHRNB2 P17787 1/20 0.46
CHRNA7 P36544 1/20 0.46
CHRNA4 P43681 1/20 0.46
FNTA P49354 7/20 0.45
FNTB P49356 7/20 0.45
KDM4E B2RXH2 1/20 0.41
GABRP O00591 1/20 0.41
GABRD O14764 1/20 0.41
IKBKB O14920 1/20 0.41
AURKA O14965 1/20 0.41
CHUK O15111 1/20 0.41
ALDH1A1 P00352 1/20 0.41
PIM1 P11309 1/20 0.41
TOP1 P11387 1/20 0.41
GABRA1 P14867 1/20 0.41
IDO1 P14902 1/20 0.41
HPGD P15428 1/20 0.41
GABRB1 P18505 1/20 0.41
GABRG2 P18507 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6345506 0.81 ALDH1A1 (0.59) TBXAS1KDM4EALDH1A1
SCHEMBL8253461 0.79 CHRNB2 (0.56) TBXAS1CHRNB2CHRNA7CHRNA4KDM4E
SCHEMBL13654133 0.78 HTR6 (0.52) CHRNB2CHRNA7CHRNA4FNTAFNTB
SCHEMBL7749049 0.77 TBXAS1 (0.52) TBXAS1CHRNB2CHRNA7CHRNA4KDM4E
SCHEMBL10953031 0.77 HTR6 (0.58) FNTAFNTB
SCHEMBL6341806 0.75 TBXAS1 (0.54) TBXAS1FNTAFNTB
SCHEMBL13408067 0.75 TBXAS1 (0.56) TBXAS1CHRNB2CHRNA7CHRNA4KDM4E
SCHEMBL11346119 0.72 TBXAS1 (1.00) TBXAS1SMN1; SMN2
Hydrochloric Acid SCHEMBL11488603 0.71 TBXAS1 (0.97) TBXAS1SMN1; SMN2
SCHEMBL6216616 0.71 CHRNB2 (0.55) TBXAS1CHRNB2CHRNA7CHRNA4KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977370-B2 (Hetero)aryl cyclohexane derivatives GRUENENTHAL GMBH (DE) 2011-07-12 US disclosed
US-20090247573-A1 (HETERO)ARYL CYCLOHEXANE DERIVATIVES GRUNENTHAL GMBH (DE) 2009-10-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247573-A1 (HETERO)ARYL CYCLOHEXANE DERIVATIVES OPRL1, OPRM1, OPRD1 TBXAS1 918/4885CHRNB2 171/4885CHRNA7 221/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.